What is the global peptic ulcer Market?

The global peptic ulcer drugs market encompasses all products used to treat peptic ulcers - sores in the stomach lining or esophagus that affect eating or drinking habits - around the globe.

What is the size of the global peptic ulcer drugs market?

The Global peptic ulcer drugs market size is expected to be worth around US$ 6.4 Bn by 2032 from US$ 4.6 Bn in 2022, growing at a CAGR of 3.5% during the forecast period from 2023 to 2032.

What are the key factors driving the growth of the global peptic ulcer drugs market?

The Rising prevalence of peptic ulcer to support the market growth. Awareness about the peptic ulcer drugs and sedentary lifestyle of individuals to propel the market growth.

Which regions have the largest share of the global peptic ulcer drugs market?

The regions having the largest share of the global peptic ulcer drugs market North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Who are the major players in the global peptic ulcer drugs market?

The major players in the global peptic ulcer drugs market include Abbott, AstraZeneca plc, Zydus Lifesciences Limited, Boehringer Ingelheim International GmbH, Novitium Pharma, Yuhan Corporation, Pfizer Inc., Pharmaking Co. Ltd., Viatris Inc., RedHill Biopharma Ltd., Novartis AG, Other Key Players.

What are some challenges facing the global peptic ulcer drugs market?

Some challenges facing the rising global prevalence of peptic ulcers, some factors are expected to limit the growth of the drug market. ADRs associated with the usage of peptic ulcer drugs, such as the side effects of PPI, include the increased risk of gastroenteritis, nutritional deficiencies (vitamin B12, magnesium), bowel upset, and diarrhea.

What is the outlook for the global peptic ulcer drugs market?

The future looks bright for the global peptic ulcer drugs market, with increasing demand for combination therapies and development of new drugs anticipated to fuel its expansion in coming years. However, competitors such as generic medications may present challenges to this growth path and emergent threats could arise from such competition.

Global Peptic Ulcer Drugs Market By Drug Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker, H2-Antagonists, Antacids, Antibiotics, and Ulcer protective), By Indication (Duodenal Ulcer, Gastric Ulcer, Gastroesophageal Reflux Disease, Gastritis, and Other Indications), By Distribution Channel, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Published date: Oct 2023
Report ID: 100148
Number of Pages: 365
Format:

- Abbott Laboratories
- AstraZeneca Plc Company Profile
- Zydus Lifesciences Limited
- Boehringer Ingelheim International GmbH
- Novitium Pharma
- Yuhan Corporation
- Pfizer Inc Company Profile
- Pharmaking Co. Ltd.
- Viatris Inc.
- RedHill Biopharma Ltd.
- Novartis AG Company Profile
- Other Key Players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 100148
Published Date Oct 2023
Rating
- ★★★★★
  
  ★★★★★
- (32)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)